目的总结经皮肺穿刺活检在诊断肺部恶性肿瘤中的应用经验,探讨其临床价值并分析影响病理类型准确性的相关因素。方法选取71例最终诊断为肺部恶性肿瘤的患者,均行经皮肺穿刺活检,就诊断结果的病理类型准确性进行统计,总结影响诊断结果的相关因素,并分析出现假阴性诊断的原因。结果经皮肺穿刺活检在肺部恶性肿瘤阳性确诊率为92.96%,肿瘤直径为3~5 cm时,漏诊率最高,达到80.00%。诊断准确率与病灶深度、有无坏死或感染无明显相关性(P>0.05)。结论肺部穿刺活检在诊断肺部恶性肿瘤中效果显著,具有较高的阳性确诊率,能够为进一步的治疗提供有效的参考信息,但需要注意相关因素的影响,必要时借助其他手段确诊。
ObjectiveTo summarize the experience of percutaneous pulmonary biopsy applied to the diagnosis of pulmonary malignancy, then to explore its clinical value and analyze the related factors influencing the diagnostic accuracy for pathological types. MethodsTotally 71 patients definitely diagnosed as pulmonary malignancy were selected. All patients received percutaneous pulmonary biopsy. The diagnostic accuracy for the pathological type was assessed, the factors influencing the diagnostic results were summarized, and the causes of false-negative diagnostic results were analyzed. ResultsThe positive rate of percutaneous pulmonary biopsy for diagnosing malignant lung tumor was 92.96%.The rate of missed diagnosis was the highest (80.00%) when the diameter of tumor was 3-5cm. Diagnostic accuracy did not correlate to the depth of the lesion, the occurrence of necrosis or infection (P>0.05). ConclusionPulmonary biopsy is effective for diagnosing pulmonary malignancy, achieves a high positive rate for diagnosis, and can provide effective reference for further therapy. However, the relevant influencing factors should be taken into account, and other auxiliary approaches can be chosen for definite diagnosis if necessary.